| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Tsz Ho Tony Lau last filed a Form 4 in June 2021, as Director at CELH. Tsz Ho Tony Lau's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Tsz Ho Tony Lau has 9 Form 4 filings on record from August 2017 to June 2021, across 2 companies: Director at Niagen Bioscience (NAGE), 2017–2021; Director at Celsius (CELH), 2018–2021.
The 13 reported transactions were 8 option or other derivative awards, 4 tax withholdings and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $9.4M.
The only open-market sale was 150,000 shares of CELH at an average $62.50 on June 14, 2021, about $9.4M. Twelve months later CELH was down 11%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2021 | CELH Celsius Holdings, Inc. | Director | Sell | 150,000 | $62.50 | $9,375,000.00 | -100% | +34.7% | -10.8% |